Results 191 to 200 of about 76,436 (232)

Dilemmas and Challenges in the Anesthetic Management of Liver Transplantation for Transthyretin Amyloidosis in the Asian Context: A Case Report. [PDF]

Cureus
Yek J, Chan S, Tay SM, Tan S.
europepmc   +1 more source

Antifungal exposure can enhance Candida glabrata pathogenesis

Ribeiro GF, Danecka W, Tomlinson L, Wallace EW, Childers DS.   +4 more
europepmc   +1 more source

Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to potentiate the activity bedaquiline and other antitubercular drugs

Fountain AJ, Waller NJ, Cheung C, Jowsey W, Chrisp MT, Troll M, Edelstein PH, Cook GM, McNeil MB, Ramakrishnan L.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ionization and Surface Properties of Verapamil and Several Verapamil Analogues

Journal of Pharmaceutical Sciences, 1986
We have investigated the ionization and surface properties of verapamil (5-[(3,4-dimethoxyphenethyl)methylamino]-2-(3, 4-dimethoxyphenyl)-2-isopropylvaleronitrile, 1) and several verapamil analogues since these properties appear to be involved in the biologic activities of these compounds.
Gregory S. Retzinger, S.H. Lau, Louis Cohen, Ferenc J. Kezdy   +3 more
openaire   +3 more sources

Clinical Pharmacokinetics of Verapamil

Clinical Pharmacokinetics, 1984
Verapamil is widely used in the treatment of supraventricular tachyarrhythmias as well as for hypertension and control of symptoms in angina pectoris. Unlike other calcium antagonists, detailed pharmacokinetic data are available for verapamil. Plasma concentrations of verapamil appear to correlate with both electrophysiological and haemodynamic ...
Scott R. Hamann, Scott R. Hamann, Robert A. Blouin, Robert A. Blouin, R. G. McAllister, R. G. McAllister   +5 more
openaire   +3 more sources

Verapamil and Pulmonary Hypertension

Acta Medica Scandinavica, 1978
ABSTRACT.We report on the effect of verapamil in 12 patients suffering from pulmonary hypertension. The drug caused a slight, but statistically significant decrease in mean pulmonary artery pressure and in the work performance by the right ventricle. The mean pressure of the right atrium, the end‐diastolic pressure of the right ventricle, the pulmonary
Knud Landmark, Ole Storstein, Anne Mane Refsum, Svein Simonsen   +3 more
openaire   +3 more sources

Precipitation of Verapamil

Annals of Internal Medicine, 1982
Excerpt To the editor: Verapmil has been recently approved by the FDA for the treatment of supraventricular tachycardia.
John A. Marx, Kenneth W. Kulig, David Bar-Or, Peter Rosen   +3 more
openaire   +2 more sources

Tachyphylaxis to Verapamil

Archives of Internal Medicine, 1986
To the Editor. —The use of verapamil hydrochloride was shown to be effective for either prevention 1 or treatment of episodes of supraventricular tachycardia. 2 Recently, we observed an unusual phenomenon of tachyphylaxis using this agent. Report of a Case.
Dan Aderka, Jack Pinkhas, Ariel Levy
openaire   +2 more sources

Verapamil for ventricular tachycardia

The American Journal of Emergency Medicine, 2007
Fascicular ventricular tachycardia (VT; also known as left VT) belongs to a subclass of idiopathic VTs. It can be confused with VT and supraventricular tachycardia. It is an entity well recognized by the cardiology community but not as frequently by emergency medicine physicians because of its infrequency. Idiopathic left VT was first described in 1979.
Huck Chin Chew, Swee Han Lim
openaire   +3 more sources